RBC Europe’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-47
| Closed | -$2.31K | – | 681 |
|
|
2021
Q3 | $2.31K | Hold |
47
| – | – | ﹤0.01% | 1114 |
|
|
2021
Q2 | $2.66K | Hold |
47
| – | – | ﹤0.01% | 1097 |
|
|
2021
Q1 | $2.68K | Hold |
47
| – | – | ﹤0.01% | 1056 |
|
|
2020
Q4 | $3.17K | Buy |
47
+20
| +74% | +$1.35K | ﹤0.01% | 1018 |
|
|
2020
Q3 | $6.77K | Buy |
+27
| New | +$6.77K | ﹤0.01% | 865 |
|
|
2018
Q1 | – | Sell |
-31
| Closed | -$1.84K | – | 1129 |
|
|
2017
Q4 | $1.84K | Hold |
31
| – | – | ﹤0.01% | 1054 |
|
|
2017
Q3 | $1.93K | Buy |
+31
| New | +$1.93K | ﹤0.01% | 1051 |
|